|
Market Closed -
Nasdaq
01:30:00 24/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 16.57 USD | -1.72% |
|
+2.28% | -3.52% |
| 16/10 | Omeros Shares Fall After Narsoplimab Application Rejected Again by EU Agency | MT |
| 16/10 | Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Friday Amid Investor Caution | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 119.95Cr | - | - | - | - | |
| 6.47TCr | |||||
| 5.48TCr | |||||
| 5.35TCr | |||||
| 4.6TCr | |||||
| 4.29TCr |
- Stock Market
- Stocks
- OMER Stock
- Charts Omeros Corporation
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
